# A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases

> **NCT07448298** · EARLY_PHASE1 · RECRUITING · sponsor: **Beijing Boren Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Relapsed/Refractory Autoimmune Diseases

## Interventions

- **BIOLOGICAL:** AFN50 injection

## Key facts

- **NCT ID:** NCT07448298
- **Lead sponsor:** Beijing Boren Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-09
- **Primary completion:** 2028-02-29
- **Final completion:** 2029-02-28
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07448298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07448298, "A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07448298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*